| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.045 | 0.4 |